Hainan Shuangcheng Pharmaceuticals Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 129.76 million compared to CNY 114.8 million a year ago. Revenue was CNY 139.01 million compared to CNY 126.81 million a year ago.

Net income was CNY 8.79 million compared to net loss of CNY 1.81 million a year ago. Basic earnings per share from continuing operations was CNY 0.0214 compared to basic loss per share from continuing operations of CNY 0.0045 a year ago. Diluted earnings per share from continuing operations was CNY 0.0214 compared to diluted loss per share from continuing operations of CNY 0.0045 a year ago.